Suchergebnisse - "Garassino, Marina"

PubPharm (344)

1

Pembrolizumab Plus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1% : Pooled Analysis of Outcomes After 5 Years of Follow-Up

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Gadgeel, S. | Rodríguez-Abreu, D. | Halmos, B. | +7

2

Mesothelioma : Pleural, Version 1.2024

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2024

von Stevenson, J. | Ettinger, D. | Wood, D. | +42

3

Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Hines, J. | Cameron, R. | Esposito, A. | +16

4

Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer : Interim Results of the MAURIS Phase IIIb Trial

enthalten in: The oncologist | 2024

von Bria, E. | Morgillo, F. | Garassino, M. | +18

5

Nivolumab in pretreated pleural mesothelioma : Results from an observational real-world study of patients treated within the AIFA 5% Fund

enthalten in: Tumori | 2024

von Cerbone, L. | Delfanti, S. | Crivellari, S. | +18

6

Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN) : Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Paz-Ares, L. | Garassino, M. | Chen, Y. | +19

CommentIn: Clin Cancer Res. 2024 Feb 16;30(4):652-654. - PMID 38085269

7

Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer : Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Gridelli, C. | Peters, S. | Mok, T. | +4

8

Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer : Results From the CANOPY-1 Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Tan, D. | Felip, E. | de Castro, G. | +20

9

Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy

enthalten in: Journal of experimental & clinical cancer research : CR | 2024

von Ndembe, G. | Intini, I. | Moro, M. | +13

10

Response to Letter to the Editor From Shaorong Yu and Jifeng Feng

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Garassino, M. | Faivre-Finn, C.

CommentOn: J Thorac Oncol. 2024 Jan;19(1):173-174. - PMID 38185511

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[35]